Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication
Having secured one of last year’s largest funding rounds, AI-focused Formation Bio is now eyeing up to 545 million euros ($626 million) from a licensing deal with Sanofi.
